10-Q: Colgate-Palmolive Reports Mixed Q2 Results Amid Macro Headwinds, Launches New Productivity Program

Colgate-Palmolive reported a 1.0% increase in Q2 net sales and a 1.8% organic sales growth, but faced declining gross profit margins and operating profit, while announcing a new three-year productivity program and navigating ongoing legal and macroeconomic challenges.

Summary

• Net sales for the second quarter of 2025 increased by 1.0% to $5,110 million, compared to $5,058 million in the second quarter of 2024.
• Organic sales grew by 1.8% in Q2 2025, driven by net selling price increases of 2.0%.
• Gross profit margin decreased to 60.1% in Q2 2025 from 60.6% in Q2 2024 (GAAP), primarily due to significantly higher raw and packaging material costs (420 basis points).
• Operating profit decreased by 1% to $1,080 million in Q2 2025 from $1,092 million in Q2 2024.
• Net income attributable to Colgate-Palmolive Company increased to $743 million in Q2 2025 from $731 million in Q2 2024.
• Diluted earnings per common share increased to $0.91 in Q2 2025 from $0.89 in Q2 2024.
• For the six months ended June 30, 2025, net sales decreased by 1.0% to $10,021 million, while organic sales increased by 1.6%.
• The Hills Pet Nutrition segment saw net sales increase by 3.8% in Q2 2025 to $1,157 million, with organic sales growth of 2.0%, despite a negative impact from lower private label pet volume.
• The company acquired Care TopCo Pty Ltd (Prime100 pet food business) for approximately $301 million on April 30, 2025, expanding into the fresh pet food category in Australia.
• A new three-year Productivity Program was approved on July 31, 2025, projected to incur cumulative pre-tax charges of $200 million to $300 million by December 31, 2028.
• The company recorded a $65 million charge in Q1 2025 related to the ERISA litigation matter, with a settlement in principle reached in Q2 2025 for the previously recorded charges.
• The quarterly common stock dividend was increased to $0.52 per share from $0.50 per share, effective Q2 2025.
• The Board authorized a new $5 billion share repurchase program on March 20, 2025, with $4,744 million remaining under the program as of June 30, 2025.
• Total debt increased to $8,758 million as of June 30, 2025, from $7,949 million at December 31, 2024, partly due to the issuance of $500 million in five-year Senior Notes in April 2025.

Sentiment

Score: 5

Explanation: The filing presents a mixed financial picture. While organic sales and EPS showed growth, overall net sales for the six-month period declined, and gross profit margins and operating profit faced pressure in Q2 due to high costs. The company is actively addressing challenges with a new productivity program and strategic acquisition, but the outlook remains cautious due to persistent macroeconomic headwinds, tariffs, and ongoing legal matters. The sentiment is neutral to slightly negative, reflecting the significant external pressures and some internal financial declines despite strategic efforts.

Positives

• Organic sales growth of 1.8% in Q2 2025 and 1.6% for the first six months of 2025, indicating underlying business strength despite external factors.
• Diluted earnings per common share increased to $0.91 in Q2 2025 from $0.89 in Q2 2024, and to $1.76 for the first six months of 2025 from $1.71 in the comparable 2024 period.
• The Hills Pet Nutrition segment demonstrated strong performance with net sales up 3.8% and operating profit up 13% in Q2 2025.
• The acquisition of Prime100 pet food business provides entry into the fast-growing fresh pet food category in Australia, enhancing the Hills Pet Nutrition portfolio.
• Approval of a new three-year Productivity Program is expected to drive future growth, optimize the global supply chain, and reduce overhead costs.
• The company increased its quarterly common stock dividend to $0.52 per share, reflecting confidence in future cash flows.
• A new $5 billion share repurchase program was authorized, demonstrating a commitment to returning capital to shareholders.
• Settlement in principle reached for the ERISA litigation matter, resolving a long-standing legal issue for the amount previously charged.

Negatives

• Worldwide net sales for the first six months of 2025 decreased by 1.0% compared to the first six months of 2024, primarily due to negative foreign exchange impacts.
• Gross profit margin decreased to 60.1% in Q2 2025 from 60.6% in Q2 2024 (GAAP), largely due to significantly higher raw and packaging material costs (420 basis points).
• Operating profit decreased by 1% in Q2 2025 and non-GAAP operating profit decreased by 3% in Q2 2025, indicating pressure on profitability.
• Net cash provided by operations decreased by 11% to $1,484 million in the first six months of 2025, compared to $1,671 million in the first six months of 2024, primarily due to changes in working capital.
• The company continues to face a growing number of talcum powder lawsuits, with 384 individual cases pending as of June 30, 2025, an increase from prior periods.
• North America and Latin America segments experienced declines in net sales in Q2 2025, with North America also seeing a decrease in organic sales.
• Advertising investment decreased as a percentage of Net sales to 13.3% in Q2 2025 from 14.0% in Q2 2024, and 2% in absolute terms for the six months, which could impact brand visibility.

Risks

• Global macroeconomic, political, and market conditions are expected to remain challenging due to inflation, high interest rates, and foreign currency volatility.
• Developments in trade relations, including the imposition of tariffs by the United States and other countries, are expected to contribute to inflationary pressures and geopolitical tensions, with an estimated incremental gross cost of approximately $75 million in 2025.
• Tariffs, inflationary pressures, and high interest rates may negatively impact consumer consumption or discretionary spending, potentially leading to reduced demand or a shift to lower-priced product offerings.
• Continued volatility in foreign currency fluctuations is expected, particularly in hyper-inflationary economies like Argentina, Nigeria, and Trkiye.
• Higher raw and packaging material costs persist, and it may become increasingly difficult to implement mitigation strategies effectively in the current environment.
• Heightened competitive activity from strong local competitors, other large multinational companies, and new market entrants, including aggressive product claims, marketing challenges, and increased promotional spending.
• Changes in policies and practices of retail trade customers, such as inventory destocking, fulfillment requirements, technology-aided pricing pressures, and limitations on shelf space, could negatively affect the business.
• The evolving retail landscape, including the continued growth of eCommerce and alternative retail channels, may create pricing pressures and/or adversely affect relationships with key retailers.
• Geopolitical events and tensions, such as the war in Ukraine, the conflict in the Middle East, and tensions between China and Taiwan, could impact supply chains, material costs, and consumer sentiment.
• The fair value of one indefinite-lived trademark intangible asset exceeded its carrying value by less than 20%, indicating a potential risk of impairment charges in future periods if estimates change.
• Ongoing federal, state, and international income tax audits, including a dispute with the IRS regarding an estimated $160 million tax assessment for years 2010-2018, pose a financial risk despite management's belief of prevailing.

Future Outlook

The company anticipates global macroeconomic, political, and market conditions to remain challenging, citing inflation, high interest rates, foreign currency volatility, and trade relations/tariffs as key contributors to consumer uncertainty. It expects continued volatility across all categories and higher raw and packaging material costs. Despite these challenges, the company believes its strong financial condition, experience in challenging environments, resilient global supply chain, and focused business strategy, including science-led innovation and operational efficiencies, position it well to manage through these conditions and increase shareholder value over time. The new Productivity Program is designed to support the 2030 strategy by aligning organizational structure, optimizing the global supply chain, and reducing overhead costs.

Management Comments

• "We expect global macroeconomic, political and market conditions to remain challenging, including as a result of inflation, high interest rates, foreign currency volatility and developments in trade relations resulting from the imposition of (and the potential for additional) tariffs by the United States and other countries, contributing to uncertainty for consumers."
• "We believe that we are well prepared to meet the challenges ahead due to our strong financial condition, experience operating in challenging environments, resilient global supply chain, dedicated and diverse global team and focused business strategy."
• "Our strategy is based on delivering consistent compounded earnings per share growth through driving organic sales growth and operational efficiencies and leveraging the strength of our balance sheet."

Industry Context

The consumer staples industry, particularly in household and personal care, continues to face significant macroeconomic headwinds including persistent inflation, high interest rates, and volatile foreign exchange rates, which impact both input costs and consumer purchasing power. Geopolitical tensions and trade tariffs further complicate global supply chains and pricing strategies. The shift towards e-commerce and alternative retail channels is accelerating, requiring companies to adapt their distribution and marketing strategies. Competition remains intense, with both established multinational players and agile local brands vying for market share. Companies like Colgate-Palmolive are responding by focusing on productivity programs, strategic acquisitions in high-growth segments like premium pet food, and leveraging innovation to maintain brand relevance and market share.

Comparison to Industry Standards

• Colgate-Palmolive's organic sales growth of 1.8% in Q2 2025 is a positive indicator, aligning with or potentially exceeding growth rates seen by some peers in the consumer staples sector that are also navigating inflationary environments and shifting consumer behaviors.
• The decline in gross profit margin by 50 basis points (GAAP) in Q2 2025 due to higher raw and packaging material costs is a common challenge across the consumer goods industry, with many companies like Procter & Gamble or Unilever reporting similar pressures on their cost of goods sold.
• The company's strategic acquisition of Prime100 pet food business for $301 million reflects an industry trend of major consumer goods companies investing in high-growth, premium segments, similar to Nestlé's continued expansion in pet care or Mars Petcare's diversified portfolio.
• The new three-year productivity program, targeting $200 million to $300 million in pre-tax charges, is a standard industry response to cost pressures, mirroring efficiency initiatives undertaken by peers to offset inflation and fund growth investments.
• The increase in talcum powder litigation cases, while specific to Colgate-Palmolive, highlights broader product liability risks faced by consumer goods companies, comparable to the legal challenges faced by Johnson & Johnson regarding its talc-based products.
• The company's focus on science-led innovation and expanding in faster-growing channels (e.g., e-commerce) is consistent with best practices in the consumer staples industry to drive household penetration and brand health in a competitive and evolving retail landscape.

Corporate Governance

Legal Proceedings

• Brazilian Tax Matters: The company is disputing approximately $108 million in tax assessments (with interest, penalties, and fees) related to interest deductions and foreign exchange losses from the 1995 Kolynos acquisition. Three lawsuits are pending in the Lower Federal Court, and two cases have been appealed to the Federal Court of Appeals. The Brazilian tax authority reduced claims in two actions in August 2024 and one in October 2024 related to the penalty portion.
• Brazilian Tax Assessment (Foreign Exchange): The company is disputing a $26 million tax assessment (with interest and fees) from December 2005 related to a tax on foreign exchange transactions. A lawsuit is filed in Brazilian federal court after administrative appeals were denied. The Brazilian tax authority reduced its claim in March 2025.
• Brazilian Civil Action: A civil action filed in July 2002 seeks to annul a tax appeals decision and make the company's Brazilian subsidiary jointly and severally liable for any tax due from the seller of Kolynos. The case is pending in the Lower Federal Court.
• Talcum Powder Matters: As of June 30, 2025, there were 384 individual cases pending against the company alleging asbestos contamination and/or causing mesothelioma and other cancers. 62 new cases were filed and 27 resolved in Q2 2025. The company believes it has strong legal grounds and expects insurance coverage for a significant portion of costs. One case that resulted in a jury verdict in favor of the company in March 2024 was settled for an immaterial amount in Q2 2025 after appeal.
• ERISA Matter: A lawsuit filed in June 2016 alleged improper calculation of residual annuity payments for the Retirement Plan. The District Court granted summary judgment to plaintiffs, affirmed by the Second Circuit in March 2023. The District Court's decision on calculation issues was affirmed by the Second Circuit in April 2025. The company recorded charges of $267 million in Q1 2023 and $65 million in Q1 2025. A settlement in principle was reached in Q2 2025 for the previously recorded charges, subject to court approval, requiring immaterial cash contributions in 2025.

Stakeholder Impact

• Shareholders: Benefit from increased dividends and ongoing share repurchase programs, but face potential risks from macroeconomic headwinds, increased costs, and ongoing legal proceedings that could impact future returns.
• Employees: The new Productivity Program includes initiatives to better align organizational structure and streamline operations, which may lead to workforce adjustments.
• Customers: May experience potential pricing actions due to increased costs, but also benefit from new product introductions like Prime100 pet food and continued investment in innovation.
• Suppliers: The company has agreements for supplier finance programs, which facilitate their ability to finance payment obligations with third-party financial institutions.
• Creditors: The company's debt increased, but it maintains strong cash generation and broad access to global credit and capital markets, indicating continued ability to meet obligations.

Next Steps

• Finalize the purchase price allocation for the Prime100 acquisition no later than the second quarter of 2026.
• Implement the new three-year Productivity Program, with substantially all charges expected to be incurred by December 31, 2028.
• Continue to evaluate the impact of the One Big Beautiful Bill Act (OBBBA) on Consolidated Financial Statements.
• Monitor and evaluate the impact of Pillar II Model Rules and related regulations on Consolidated Financial Statements as they are revised and implemented.
• Continue to contest Brazilian tax assessments and civil actions vigorously, with ongoing lawsuits and potential appeals.
• Continue to vigorously challenge talcum powder civil actions, expecting a portion of costs to be covered by insurance policies.
• Seek court approval for the settlement in principle reached for the ERISA litigation matter.
• Make immaterial cash contributions to U.S. postretirement plans and for the ERISA settlement during the remainder of 2025.
• Continue to focus capital spending on projects expected to yield high after-tax returns, with capital expenditures expected to be approximately 3.0% of Net sales for 2025.
• Continue share repurchases under the new $5 billion 2025 Program.
• Jennifer M. Daniels' 10b5-1 trading plan will continue until its termination on December 5, 2025, unless terminated sooner.

Key Dates

Recommendation

Colgate-Palmolive's Q2 2025 results present a mixed picture, warranting a 'hold' recommendation. While organic sales growth and EPS increases are positive, the decline in overall net sales for the six-month period and the compression in gross profit margins and operating profit in Q2 due to higher raw material costs are concerning. The company is proactively addressing challenges with a new productivity program and a strategic acquisition in pet nutrition, which are favorable long-term moves. However, the persistent macroeconomic headwinds, including inflation, high interest rates, and tariffs, coupled with ongoing significant legal liabilities (talcum powder and tax disputes), introduce considerable uncertainty. The company's strong brand portfolio and global footprint provide resilience, but the immediate outlook suggests continued pressure on profitability and cash flow from operations. A seasoned investor would likely observe how the new productivity initiatives impact margins and how the company navigates the challenging cost and geopolitical environment before making a more decisive move.

Keywords

Consumer staples, Personal care, Oral care, Home care, Pet nutrition, SEC filing, 10-Q, Earnings, Sales growth, Profit margin, Acquisition, Productivity program, Tariffs, Inflation, Foreign exchange, Legal proceedings, Share repurchase, Dividend